Back
Freeport-McMoRan, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
72
FCX
Freeport-McMoRan, Inc.
Last Price:
$49.13
Seasonality Move:
7.92%
Buy
78
KYMR
Kymera Therapeutics, Inc.
Last Price:
$83.94
Seasonality Move:
-2.06%
Buy
72
Freeport-McMoRan, Inc. (FCX)
is a Buy
Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?
-
The current Freeport-McMoRan, Inc. [FCX] share price is $49.15. The Score for FCX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $83.99. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FCX Stock Price Chart
What is Freeport-McMoRan, Inc.'s stock price today?
-
The Freeport-McMoRan, Inc. share price today is $49.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $83.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.87 | Buy |
| Relative Strength Index (14 RSI): | 74.86 | Buy |
| Chaikin Money Flow: | 8327699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.83 - 47.09) | Buy |
| Bollinger Bands (100): | (39.73 - 45.23) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.67 | Buy |
| Relative Strength Index (14 RSI): | 61.09 | Buy |
| Chaikin Money Flow: | 904128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.53 - 84.49) | Buy |
| Bollinger Bands (100): | (43.76 - 70.14) | Buy |
FCX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.74 | Buy |
| 20-day SMA: | 44.95 | Buy |
| 50-day SMA: | 42.55 | Buy |
| 200-day SMA: | 41.03 | Buy |
| 8-day EMA: | 47.51 | Buy |
| 20-day EMA: | 45.55 | Buy |
| 50-day EMA: | 43.58 | Buy |
| 200-day EMA: | 42.07 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.37 | Sell |
| 20-day SMA: | 76.38 | Buy |
| 50-day SMA: | 67.14 | Buy |
| 200-day SMA: | 46.64 | Buy |
| 8-day EMA: | 82.78 | Buy |
| 20-day EMA: | 77.85 | Buy |
| 50-day EMA: | 68.99 | Buy |
| 200-day EMA: | 52.52 | Buy |
Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.25 per share.
Freeport-McMoRan, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||